Device Trial Radar · NCT04607746
Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference
Last checked: Nov 19, 2026Latest source record: Jul 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,337
Actual
Start
Jan 6, 2021
Primary completion
Feb 14, 2025
Study completion Feb 14, 2025
Sponsor
- Lead sponsor
- Capso Vision, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 29, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and effectiveness of the CapsoCam Colon (CV-3) endoscope system for the detection of colonic polyps.
Conditions
- Colonic Polyp
Interventions
Capsule EndoscopeDevice
Capsule endoscope used to view colonic mucosa
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive Percent Agreement/Negative Percent AgreementTime frame: 6 weeks
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Scottsdale, Arizona
Gastro Care Institute
Lancaster, California
inSite Digestive Health Care
Los Gatos, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.